HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes

Journal of General Virology

Volumn 90, Issue 8, 2009, Pages 1806-1811

  Suemori, Koichiro ^a   Fujiwara, Hiroshi ^a   Ochi, Toshiki ^a   Ogawa, Taiji ^a   Matsuoka, Masao ^b   Matsumoto, Tadashi ^c   Mesnard, Jean Michel ^d   Yasukawa, Masaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Jiaikai Imamura Hospital   (Japan)

^d University of Montpellier I and II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; HBZ PROTEIN, HUMAN T CELL LEUKEMIA VIRUS TYPE I; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; VIRUS ANTIGEN; VIRUS PROTEIN;

ARTICLE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL LEUKEMIA; CYTOTOXICITY TEST; IMMUNOLOGY; TUMOR CELL LINE;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ANTIGENS, VIRAL; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 69449104034     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.010199-0     Document Type: Article

References (20)

1. Azuma, T., Otsuki, T., Kuzushima, K., Froelich, C., Fujita, S. & Yasukawa, M. (2004). Myeloma cells are highly sensitive to granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Clin Cancer Res 10, 7402-7412.
2. Balaji, K. N., Schaschke, N., Machleidt, W., Catalfamo, M. & Henkart, P. A. (2002). Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 196, 493-503.
3. Basbous, J., Arpin, C., Gaudray, G., Piechaczyk, M., Devaux, C. & Mesnard, J. M. (2003). The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 278, 43620-43627.
4. Bird, C. H., Sutton, V. R., Sun, J., Hirst, C. E., Novak, A., Kumar, S., Trapani, J. A. & Bird, P. I. (1998). Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 18, 6387-6398.
5. Fujiwara, H., Ozaki, A., Yoshimitsu, M., Hamada, H., Masamoto, I., Matsushita, K., Yasukawa, M. & Tei, C. (2008). Allogeneic stem cell transplantation for refractory adult T-cell leukemia using a non-T-cell-depleted HLA-incompatible family donor graft, with reference to the grown-up child donor to parent recipient setting: report of a pilot study. Int J Hematol 87, 319-326.
6. Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C. & Mesnard, J. M. (2002). The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76, 12813-12822.
7. Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A. & other authors (2004). Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64, 391-399.
8. Jiang, S. B., Ojcius, D. M., Persechini, P. M. & Young, J. D. (1990). Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins. J Immunol 144, 998-1003.
9. + T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98, 1872-1881.
10. Lehmann, C., Zeis, M., Schmitz, N. & Uharek, L. (2000). Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 96, 594-600.
11. Lemasson, I., Lewis, M. R., Polakowski, N., Hivin, P., Cavanagh, M. H., Thébault, S., Barbeau, B., Nyborg, J. K. & Mesnard, J. M. (2007). HTLV-1 bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 81, 1543-1553.
12. Muller, C. & Tschopp, J. (1994). Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J Immunol 153, 2470-2478.
13. Odeberg, J., Browne, H., Metkar, S., Froelich, C. J., Brandén, L., Cosman, D. & Söderberg-Nauclér, C. (2003). The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J Virol 77, 4539-4545.
14. + cytotoxic T-lymphocyte specific for WT1 peptide. Blood 95, 286-293.
15. Satou, Y. & Matsuoka, M. (2007). Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia. Int J Hematol 86, 107-112.
16. Satou, Y., Yasunaga, J., Yoshida, M. & Matsuoka, M. (2006). HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103, 720-725.
17. Suemori, K., Fujiwara, H., Ochi, T., Azuma, T., Yamanouchi, J., Narumi, H., Yakushijin, Y., Hato, T., Hasegawa, H. & Yasukawa, M. (2008). Identification of an epitope derived from CML66, a novel tumor-associated antigen broadly expressed in human leukemia, recognized by HLA-A 2402-restricted cytotoxic T lymphocytes. Cancer Sci 99, 1414-1419.
18. Taylor, G. P. & Matsuoka, M. (2005). Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24, 6047-6057.
19. Utsunomiya, A., Miyazaki, Y., Takatsuka, Y., Hanada, S., Uozumi, K., Yashiki, S., Tara, M., Kawano, F., Saburi, Y. & other authors (2001). Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27, 15-20.
20. + CTL directed against herpes simplex virus-infected cells. J Immunol 162, 6100-6106.